The receipt of this permission paves way for the marketing of Durvalumab solution for infusion 120 mg/2.4 mL and 500 mg/10 mL (Imfinzi) in India
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
© 2026 Wise Founders. Designed by Jackfruit Digital.